Overactive Bladder Videos

COURAGE Trial: Vibegron for BPH Patients with Persistent OAB Symptoms - David Staskin

August 9, 2024

Details

Optimizing Overactive Bladder Treatment: Phenazopyridine's Cost-Effective Approach - Anjali Kapur

August 7, 2024

Details

Oxybutynin-Associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment - Beyond the Abstract

July 10, 2024

Details

Emerging Technologies in Urology: A Glimpse Into Tibial Nerve Stimulation for Bladder Dysfunction Treatment - Diane Newman & Howard Goldman

May 30, 2023

Details

Revolutionizing Urodynamics: Uromonitor's Comfortable, Real-Life Bladder Pressure Tracking - Diane Newman & Howard Goldman

May 30, 2023

Details

Phase 2a Trial Results: Promising Gene Therapy for Overactive Bladder - URO-902 Safety and Efficacy Evaluation - Kenneth Peters

May 22, 2023

Details

Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR - Beyond the Abstract

May 19, 2022

Details

Mechanistic Pathway Through Which Saphenous Nerve Stimulation Can Modulate Bladder Function - Paul Yoo

April 24, 2022

Details

Developing A Novel Neuromodulation Therapy for Treating Overactive Bladder - Anne Agur

April 24, 2022

Details

The Effects of Vibegron on Ambulatory Blood Pressure in Patients With Overactive Bladder - Michael A. Weber

September 19, 2021

Details

The OAB Clinical Care Pathway Mobile APP - Stephen Kraus

July 30, 2021

Details

GEMTESA® (vibegron) for the Treatment of Patients with Overactive Bladder FDA Approved - Scott A. MacDiarmid

January 14, 2021

Details

Advancements in Pharmacological and Device-Based OAB Treatment Options - Eric Rovner

November 7, 2020

Details

Incontinence Options for Men and Women: Is It Safe? - Eric S. Rovner

December 17, 2019

Details

A Contemporary Assessment of Nocturia - Mikel Gray

January 29, 2019

Details